Hiroyuki Takei

3.9k total citations
195 papers, 2.9k citations indexed

About

Hiroyuki Takei is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Hiroyuki Takei has authored 195 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Cancer Research, 63 papers in Oncology and 47 papers in Pathology and Forensic Medicine. Recurrent topics in Hiroyuki Takei's work include Breast Cancer Treatment Studies (64 papers), Breast Lesions and Carcinomas (44 papers) and Estrogen and related hormone effects (24 papers). Hiroyuki Takei is often cited by papers focused on Breast Cancer Treatment Studies (64 papers), Breast Lesions and Carcinomas (44 papers) and Estrogen and related hormone effects (24 papers). Hiroyuki Takei collaborates with scholars based in Japan, United States and China. Hiroyuki Takei's co-authors include Masafumi Kurosumi, Shin Tsunekawa, Jun Horiguchi, Kenichi Inoue, Yuichi Iino, Kimito Suemasu, Yuri Yamaguchi, Seigo Nakamura, Toshio Tabei and Norikazu Masuda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Physical review. B, Condensed matter.

In The Last Decade

Hiroyuki Takei

182 papers receiving 2.8k citations

Peers

Countries citing papers authored by Hiroyuki Takei

Since Specialization

Citations

This map shows the geographic impact of Hiroyuki Takei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Takei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Takei more than expected).

Fields of papers citing papers by Hiroyuki Takei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroyuki Takei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Takei. The network helps show where Hiroyuki Takei may publish in the future.

Co-authorship network of co-authors of Hiroyuki Takei

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroyuki Takei. A scholar is included among the top collaborators of Hiroyuki Takei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroyuki Takei. Hiroyuki Takei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Harmonized pretreatment quantitative volume-based ¹⁸F-FDG PET/CT parameters for stage IV breast cancer prognosis. Multicenter study in Japan. 2024 ·PubMed ·Kazuhiro Kitajima, Yasuo Miyoshi, Tetsuro Sekine, Hiroyuki Takei, Kimiteru Ito, Akihiko Suto, Hayato Kaida, Hiromitsu Daisaki, Koichiro Yamakado	0
2	Anatomical Analysis of the Superior Gluteal Artery in 100 Women for Superior Gluteal Artery Perforator Flap Breast Reconstruction 2024 ·Plastic & Reconstructive Surgery Global Open ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hiroyuki Takei, (unknown)	1
3	Radiation-induced fibrosarcoma after breast-conserving therapy for breast cancer: a case report and literature review 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Yutaka Tsutsumi, Hiroyuki Takei	1
4	Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis 2023 ·Breast Cancer ·(unknown), Atsushi Yoshida, Osamu Takahashi, (unknown), Junko Takei, Naoki Hayashi, Hiroyuki Takei, Hideko Yamauchi	1
5	The Number of Sentinel Lymph Nodes Could be Optimized by Adjusting the Injection Dose 2021 ·SHILAP Revista de lepidopterología ·Masujiro Makita, (unknown), Michiko Sato, Hiroyuki Takei	1
6	Optimal Treatment Duration of Neoadjuvant Endocrine Therapy for Women Aged 60 Years or Older with Estrogen Receptor-Positive, HER2-Negative Invasive Breast Cancer 2020 ·Journal of Nippon Medical School ·Yuji Hayashi, Hiroyuki Takei, Tsuyoshi Saito, Toshihiro Kai, Kenichi Inoue, Masafumi Kurosumi, Jun Ninomiya	1
7	Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer 2019 ·European Journal of Cancer ·(unknown), Giampaolo Bianchini, Michiko Ando, (unknown), Daiki Kobayashi, Carmen Criscitiello, Giuseppe Curigliano, Takayuki Iwamoto, Naoki Niikura, Hiroyuki Takei, Atsushi Yoshida, Junko Takei, Koyu Suzuki, Hideko Yamauchi, Naoki Hayashi	59
8	Prognostic utility of atypical mitoses in patients with breast cancer: A comparative study with Ki67 and phosphohistone H3 2018 ·Journal of Surgical Oncology ·Ryuji Ohashi, Shigeki Namimatsu, Takashi Sakatani, Zenya Naito, Hiroyuki Takei, Akira Shimizu	17
9	Handheld magnetic probe with permanent magnet and Hall sensor for identifying sentinel lymph nodes in breast cancer patients 2018 ·Scientific Reports ·Masaki Sekino, Akihiro Kuwahata, (unknown), (unknown), (unknown), Miki Kaneko, Itsuro Saito, Yusuke Inoue, Hiroyuki Ohsaki, Hiroyuki Takei, Moriaki Kusakabe	53
10	Prognostic value of the ubiquitin ligase carboxyl terminus of the Hsc70‐interacting protein in postmenopausal breast cancer 2016 ·Cancer Medicine ·Sasagu Kurozumi, Yuri Yamaguchi, Shinichi Hayashi, Hiromi Hiyoshi, Tetsuji Suda, (unknown), Hiroshi Matsumoto, Hiroyuki Takei, Jun Horiguchi, Izumi Takeyoshi, Tetsunari Oyama, Masafumi Kurosumi	12
11	ER, PgR, Ki67, p27Kip1, and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide concomitant with trastuzumab 2015 ·BMC Cancer ·Sasagu Kurozumi, Kenichi Inoue, Hiroyuki Takei, Hiroshi Matsumoto, Masafumi Kurosumi, Jun Horiguchi, Izumi Takeyoshi, Tetsunari Oyama	52
12	The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy 2014 ·Cancer Letters ·Seung Jin Kim, Norikazu Masuda, Fumine Tsukamoto, Hideo Inaji, Futoshi Akiyama, Hiroshi Sonoo, Junichi Kurebayashi, Katsuhide Yoshidome, Masahiko Tsujimoto, Hiroyuki Takei, Shinobu Masuda, Seigo Nakamura, Shinzaburo Noguchi	12
13	Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy 2013 ·BMC Cancer ·Mamoru Takada, Toru Higuchi, (unknown), Hiroyuki Takei, Masayuki Haruta, Junko Watanabe, Fumio Kasai, Kenichi Inoue, Masafumi Kurosumi, Masaru Miyazaki, Aiko Sato‐Otsubo, Seishi Ogawa, Yasuhiko Kaneko	22
14	Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition 2011 ·Cancer Science ·Masakazu Toi, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, K Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Masahiro Takada, Takayuki Ueno, Shigetoyo Saji, (unknown), Takashi Suzuki, Hironobu Sasano	38
15	Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer 2009 ·The Breast ·Hiroyuki Takei, Masafumi Kurosumi, Takashi Yoshida, Jun Ninomiya, Yuko Ishikawa, Yuji Hayashi, (unknown), Hideki Asakawa, (unknown), Kenichi Inoue, Toshio Tabei	4
16	New Method of Estimating Effective Energy for X-ray CT Scanners 2005 ·Japanese Journal of Radiological Technology ·Hiroyuki Nagashima, (unknown), (unknown), (unknown), Hiroyuki Takei, (unknown), (unknown), (unknown), (unknown), Masao Hoshina, (unknown)	5
17	Fifteen-year Review of a Breast Cancer Screening Project in Gunma Prefecture. 1998 ·Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) ·Yukio Koibuchi, Yuichi Iino, Takao Yokoe, Hiroyuki Takei, Michio Maemura, Jun Horiguchi, Masahiro Nagasawa, (unknown), (unknown), Hiroshi Matsumoto, Jun Ninomiya, Yasuo Morishita	1
18	Immunohistochemical Expression of Metallothionein in Invasive Breast Cancer in Relation to Proliferative Activity, Histology and Prognosis 1996 ·Oncology ·Tetsunari Oyama, Hiroyuki Takei, (unknown), Yuichi Iino, Takashi Nakajima	58
19	Screening for abdominal aortic aneurysm and occlusive peripheral vascular disease in Japanese residents 1995 ·Surgery Today ·Hiroyuki Takei, Susumu Ishikawa, (unknown), (unknown), (unknown), Yasushi Sato, Masao Suzuki, (unknown), Yuichi Iino, Takao Yokoe, Yasuo Morishita	22
20	Laparoscopic Cholecystectomy in Situs Inversus Totalis 1992 ·Journal of Laparoendoscopic Surgery ·Hiroyuki Takei, (unknown), Thomas V. Clancy, (unknown)	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact